The rewards of age
Nature Neuroscience
March 25, 2013
Giving older adults the dopamine precursor drug levodopa (L-DOPA) can reduce age related abnormalities in reward-based decision making, according to a study published online this week in Nature Neuroscience.
As some people age, their ability to use information about the likelihood of rewards to make decisions degrades. Rumana Chowdhury and colleagues showed that this change in decision-making was accompanied by changes in brain activity associated with reward expectations and connectivity between the brain areas that encode reward expectation signals. Some of the signals between these brain areas are carried by the neurotransmitter dopamine. The authors found that when they gave underperforming older human adults a dose of a drug that increases dopamine levels in the brain, their sensitivity to rewards improved.
doi: 10.1038/nn.3364
Research highlights
-
Jun 29
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports